HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chan-Loi Yong Selected Research

Antiviral Agents (Antivirals)

4/2005Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.
11/2004Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chan-Loi Yong Research Topics

Disease

4Infections
11/2017 - 11/2004
2Hepatitis C
04/2005 - 11/2004
2Liver Cirrhosis (Hepatic Cirrhosis)
04/2005 - 11/2004
1Constipation
01/2014
1Nausea
01/2014
1Diarrhea
01/2014
1Hyperbilirubinemia
06/2011
1Fibrosis (Cirrhosis)
11/2004
1Inflammation (Inflammations)
04/2002
1Endotoxemia
04/2002

Drug/Important Bio-Agent (IBA)

2Protease Inhibitors (Protease Inhibitor)IBA
06/2011 - 04/2005
2Antiviral Agents (Antivirals)IBA
04/2005 - 11/2004
2BILN 2061IBA
04/2005 - 11/2004
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
04/2005 - 11/2004
1Nevirapine (Viramune)FDA Link
11/2017
1Pharmaceutical PreparationsIBA
01/2014
1faldaprevirIBA
06/2011
1Peptide Hydrolases (Proteases)FDA Link
04/2005
1Viral RNAIBA
11/2004
1p38 Mitogen-Activated Protein KinasesIBA
04/2002